Page last updated: 2024-09-03

way 123398 and sotalol

way 123398 has been researched along with sotalol in 2 studies

Compound Research Comparison

Studies (way 123398)	Trials (way 123398)	Recent Studies (post-2010) (way 123398)	Studies (sotalol)	Trials (sotalol)	Recent Studies (post-2010) (sotalol)
15	0	1	2,196	346	291

Protein Interaction Comparison

Protein	Taxonomy	sotalol (IC50)
Beta-2 adrenergic receptor	Homo sapiens (human)	3.8169
Beta-1 adrenergic receptor	Homo sapiens (human)	7.1087
Beta-3 adrenergic receptor	Homo sapiens (human)	7.2
Beta-2 adrenergic receptor	Canis lupus familiaris (dog)	5.0667

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Colatsky, TJ; Parsons, RW; Spinelli, W	1
Colatsky, TJ; Moubarak, IF; Parsons, RW; Spinelli, W	1

Other Studies

2 other study(ies) available for way 123398 and sotalol

Article	Year
Effects of WAY-123,398, a new class III antiarrhythmic agent, on cardiac refractoriness and ventricular fibrillation threshold in anesthetized dogs: a comparison with UK-68798, E-4031, and dl-sotalol. Journal of cardiovascular pharmacology, 1992, Volume: 20, Issue:6 Topics: Anesthesia; Animals; Anti-Arrhythmia Agents; Atrioventricular Node; Benzimidazoles; Dogs; Electrocardiography; Electrophysiology; Female; Heart; Heart Conduction System; Hemodynamics; In Vitro Techniques; Male; Phenethylamines; Piperidines; Purkinje Fibers; Pyridines; Refractory Period, Electrophysiological; Sotalol; Sulfanilamides; Sulfonamides; Ventricular Fibrillation	1992
Cellular electrophysiology of WAY-123,398, a new class III antiarrhythmic agent: specificity of IK block and lack of reverse use dependence in cat ventricular myocytes. Cardiovascular research, 1993, Volume: 27, Issue:9 Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Benzimidazoles; Cats; Cells, Cultured; Culture Techniques; Dogs; Dose-Response Relationship, Drug; Myocardium; Phenethylamines; Piperidines; Potassium Channels; Purkinje Fibers; Pyridines; Sotalol; Sulfanilamides; Sulfonamides	1993

Article

Year

Effects of WAY-123,398, a new class III antiarrhythmic agent, on cardiac refractoriness and ventricular fibrillation threshold in anesthetized dogs: a comparison with UK-68798, E-4031, and dl-sotalol.

Journal of cardiovascular pharmacology, 1992, Volume: 20, Issue:6

Topics: Anesthesia; Animals; Anti-Arrhythmia Agents; Atrioventricular Node; Benzimidazoles; Dogs; Electrocardiography; Electrophysiology; Female; Heart; Heart Conduction System; Hemodynamics; In Vitro Techniques; Male; Phenethylamines; Piperidines; Purkinje Fibers; Pyridines; Refractory Period, Electrophysiological; Sotalol; Sulfanilamides; Sulfonamides; Ventricular Fibrillation

1992

Cellular electrophysiology of WAY-123,398, a new class III antiarrhythmic agent: specificity of IK block and lack of reverse use dependence in cat ventricular myocytes.

Cardiovascular research, 1993, Volume: 27, Issue:9

Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Benzimidazoles; Cats; Cells, Cultured; Culture Techniques; Dogs; Dose-Response Relationship, Drug; Myocardium; Phenethylamines; Piperidines; Potassium Channels; Purkinje Fibers; Pyridines; Sotalol; Sulfanilamides; Sulfonamides

1993